⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

August 28, 2025HaematologicaOpen Access

Benchmarking prophylaxis with factor concentrates: reference data on annualized bleeding rates in children with severe hemophilia

Susanna Ranta Marloes de Kovel Martin Olivieri Kathelijn Fischer Giancarlo Castaman Christoph Königs Johannes Oldenburg Helen Pergantou Christoph Male Marijke H. Van den Berg

View Full Paper

Ask AI

Bookmark

Share

Key Points

Annualized bleeding rates were benchmarked, revealing critical data for children with severe hemophilia.
Findings show variability in bleeding rates among children, emphasizing the need for tailored treatment approaches.
Assessments of factor concentrates were conducted to establish standard reference data for hemophilia management.
Understanding these bleeding rates is vital; it can inform better prophylactic measures and treatment protocols for affected children.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Benchmarking reveals crucial reference data on annualized bleeding rates in children, suggesting new insights for hemophilia treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ranta et al. (2025) studied this question.

synapsesocial.com/papers/68bb420d2b87ece8dc957ea1 https://doi.org/10.3324/haematol.2025.288101

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1An analytical study of annual bleeding rates in haemophilia patients receiving low dose factor prophylaxis and those receiving episodic factor doses2024 · 2 citations
2Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or BRCT · 2011 · 192 citations
3Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature reviewMeta-Analysis · 2023 · 26 citations
4A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment centerRetrospective Study · 2012 · 9 citations
5Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or BRCT · 2026 · 3 citations
6Bleeding rates in patients with congenital hemophilia B without inhibitors: A systematic review and meta-analysis2025
7Break‐through bleeding in relation to pharmacokinetics of Factor VIII in paediatric patients with severe haemophilia AOriginal Research · 2017 · 6 citations
8A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centresSurvey · 2003 · 64 citations
9Association does not establish causation. Comment on: “Overuse of thrombopoietin receptor agonists driven by suboptimal response is associated with myelofibrosis in pediatric immune thrombocytopenia”Haematologica · 2026
10Frequent FLT3 and IDH co-mutations in acute myeloid leukemia with mutated NPM1, NUP98 rearrangement, and KMT2A partial tandem duplication but not rearrangement: potential for combined targeted therapyHaematologica · 2026

More from Haematologica

More from Karolinska Institutet

More from Goethe University Frankfurt

More from University Medical Center Utrecht

More from University of Bonn

More from Karolinska University Hospital

More from University Hospital Bonn

More from University Hospital Frankfurt

More from Azienda Ospedaliero-Universitaria Careggi

More from Children's Hospital Agia Sophia

More from National Hemophilia Foundation